Ebola response in Congo strained by attacks and patient escapes
Doctors working on the front lines of the Ebola outbreak in the Democratic Republic of Congo say attacks on treatment centres and fleeing patients are...
Australian researchers have created a groundbreaking “biological AI” platform that could revolutionise drug discovery by rapidly evolving molecules within mammalian cells.
Australian scientists have developed a pioneering “biological artificial intelligence (AI)” system capable of dramatically accelerating drug discovery, potentially cutting years off the development time for advanced medicines.
The platform, named PROTEUS (PROTein Evolution Using Selection), enables the rapid creation and evolution of molecules with new or enhanced functions directly inside mammalian cells. According to the University of Sydney, which led the study, this advancement paves the way for more effective gene therapies and next-generation medicines.
Researchers explained that while directed evolution has traditionally been confined to bacterial cells, PROTEUS represents a major leap by enabling such evolution within mammalian cells for the first time. This allows scientists to mimic and speed up natural selection, reducing processes that once took years to just weeks.
“What is new about our work is that directed evolution primarily works in bacterial cells, whereas PROTEUS can evolve molecules in mammal cells,” said Greg Neely, co-senior author of the study from the University of Sydney.
The research, conducted by the University of Sydney’s Charles Perkins Center and the Centenary Institute, has made PROTEUS open source. This decision aims to enable global adoption to accelerate the development of advanced enzymes, molecular tools, therapeutics, and improved gene-editing and mRNA-based medicines.
The inaugural Enhanced Games began in Las Vegas on Sunday (24 May), launching one of the most controversial experiments in modern sport, in which athletes openly compete using performance-enhancing drugs banned under traditional anti-doping rules.
A peace agreement between Washington and Tehran is yet to materialise, with U.S. President Donald Trump saying that negotiations are incomplete and an Iranian Foreign Ministry Spokesman saying that a deal isn't imminent.
A "largely negotiated" memorandum of understanding on an Iran peace deal would reopen the Strait of Hormuz, U.S. President Donald Trump said on Saturday, though the Iranian Fars news agency disputed that claim.
Police fired tear gas and clashed with protesters in central Belgrade on Saturday, as tens of thousands gathered to demand early elections and an end to the more than decade-long rule of Serbia's President Aleksandar Vučić.
The World Health Organization warned on Monday that the fast-moving Ebola outbreak in the Democratic Republic of the Congo and Uganda was outpacing response efforts, with 220 suspected deaths reported so far.
China will send an astronaut to its space station on Sunday for a one-year mission, the longest duration for the country so far. The mission will help study long-duration human physiology in space as China works toward a crewed Moon landing by 2030.
Anxiety over artificial intelligence is hardening among young workers as executives promote faster adoption and companies point to automation in fresh job cuts.
Hackers are increasingly using artificial intelligence to detect software vulnerabilities, reducing the time organisations have to respond to cyber threats, Verizon said in its annual data breach report.
China has launched the world’s first experiment to study how artificial human embryos develop in space, marking a major step in understanding whether humans could one day reproduce beyond Earth.
Japanese filmmaker Koji Fukada has said that the use of artificial intelligence (AI) to “jump straight to the result” risks undermining the purpose of art, which he believes should be rooted in self-expression and a deeper understanding of the world.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment